instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'PREDNISOLONE'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | 60 MILLIGRAM/SQ. METER, CYCLICAL (CYCLE 1: ON DAYS 1-7) | DrugDosageText | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
What was the outcome of reaction 'Sepsis'? | Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.
The treatment of adult Burkitt lymphoma with pediatric-based chemotherapy protocols usually results in high cure rates, although with significant toxicity. We report our experience with the Cancer and Leukemia Group ... | Fatal | ReactionOutcome | CC BY-NC | 34880141 | 20,994,380 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anticoagulation drug level below therapeutic'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | ASPIRIN, HEPARIN SODIUM, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,230,998 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contraindicated product administered'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,496,858 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device related thrombosis'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,474,689 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Food interaction'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | ASPIRIN, HEPARIN SODIUM, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,230,998 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric disorder'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,496,858 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,227,121 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic erosive gastritis'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,227,121 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,227,121 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,496,858 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombosis in device'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | ASPIRIN, HEPARIN SODIUM, NITROFURANTOIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,230,998 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper gastrointestinal haemorrhage'. | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | APIXABAN, ASPIRIN | DrugsGivenReaction | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
What is the weight of the patient? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | 144 kg. | Weight | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
What was the administration route of drug 'APIXABAN'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
What was the outcome of reaction 'Anticoagulation drug level above therapeutic'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,230,998 | 2021-12-09 |
What was the outcome of reaction 'Anticoagulation drug level below therapeutic'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,230,998 | 2021-12-09 |
What was the outcome of reaction 'Device related thrombosis'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,474,689 | 2021-12-09 |
What was the outcome of reaction 'Drug interaction'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,474,689 | 2021-12-09 |
What was the outcome of reaction 'Gastric disorder'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
What was the outcome of reaction 'Thrombosis in device'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
What was the outcome of reaction 'Upper gastrointestinal haemorrhage'? | Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban.
BACKGROUND Direct oral anticoagulants (DOAC) are currently the preferred agents for long-term anticoagulation in the appropriate patient with venous thromboembolism, non-valvular atrial fibrillation, and left ventricular thrombi because ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34880201 | 20,216,094 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic myeloid leukaemia'. | Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma.
A 3-year-old child was incidentally found to have chronic myelogenous leukemia (CML) during an admission for a routine ophthalmic examination under anesthesia. The child had received systemic chemotherapy and focal treatment for G... | CARBOPLATIN, ETOPOSIDE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-SA | 34880582 | 20,479,530 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma.
A 3-year-old child was incidentally found to have chronic myelogenous leukemia (CML) during an admission for a routine ophthalmic examination under anesthesia. The child had received systemic chemotherapy and focal treatment for G... | CARBOPLATIN, ETOPOSIDE, VINCRISTINE | DrugsGivenReaction | CC BY-NC-SA | 34880582 | 20,479,530 | 2021 |
What was the outcome of reaction 'Chronic myeloid leukaemia'? | Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma.
A 3-year-old child was incidentally found to have chronic myelogenous leukemia (CML) during an admission for a routine ophthalmic examination under anesthesia. The child had received systemic chemotherapy and focal treatment for G... | Recovered | ReactionOutcome | CC BY-NC-SA | 34880582 | 20,479,530 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Extrapyramidal disorder'. | Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms.
Negative symptoms of schizophrenia are among the most invalidating clinical manifestations of this disorder, and they are correlated with poorer prognosis, lower quality of life, and fewer chances for ... | AMISULPRIDE, OLANZAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34880797 | 20,354,195 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sedation'. | Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms.
Negative symptoms of schizophrenia are among the most invalidating clinical manifestations of this disorder, and they are correlated with poorer prognosis, lower quality of life, and fewer chances for ... | AMISULPRIDE, OLANZAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34880797 | 20,354,195 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms.
Negative symptoms of schizophrenia are among the most invalidating clinical manifestations of this disorder, and they are correlated with poorer prognosis, lower quality of life, and fewer chances for ... | AMISULPRIDE, OLANZAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34880797 | 20,354,195 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms.
Negative symptoms of schizophrenia are among the most invalidating clinical manifestations of this disorder, and they are correlated with poorer prognosis, lower quality of life, and fewer chances for ... | CARIPRAZINE, OLANZAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34880797 | 20,354,162 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome.
We present two cases of ChAdOx1 nCov-19 (AstraZeneca)-associated thrombotic thrombocytopenia syndrome (TTS) and cerebral venous sinus thrombosis (CVST). At the time of emergency room presen... | ARGATROBAN, DEXAMETHASONE, HUMAN IMMUNOGLOBULIN G, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34880826 | 20,386,048 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome.
We present two cases of ChAdOx1 nCov-19 (AstraZeneca)-associated thrombotic thrombocytopenia syndrome (TTS) and cerebral venous sinus thrombosis (CVST). At the time of emergency room presen... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34880826 | 20,386,048 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome.
We present two cases of ChAdOx1 nCov-19 (AstraZeneca)-associated thrombotic thrombocytopenia syndrome (TTS) and cerebral venous sinus thrombosis (CVST). At the time of emergency room presen... | 40 mg (milligrams). | DrugDosage | CC BY | 34880826 | 20,386,048 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome.
We present two cases of ChAdOx1 nCov-19 (AstraZeneca)-associated thrombotic thrombocytopenia syndrome (TTS) and cerebral venous sinus thrombosis (CVST). At the time of emergency room presen... | Fatal | ReactionOutcome | CC BY | 34880826 | 20,386,048 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.
Pancreatic cancer has a poor prognosis, and it is traditionally treated with chemotherapy. Fortunately, immunotherapy has rapidly changed the landscape of solid tumor treatment, and improving the survival of cancer... | GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY | 34880877 | 20,296,465 | 2021 |
What was the administration route of drug 'PACLITAXEL'? | Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.
Pancreatic cancer has a poor prognosis, and it is traditionally treated with chemotherapy. Fortunately, immunotherapy has rapidly changed the landscape of solid tumor treatment, and improving the survival of cancer... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34880877 | 20,296,465 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.
Pancreatic cancer has a poor prognosis, and it is traditionally treated with chemotherapy. Fortunately, immunotherapy has rapidly changed the landscape of solid tumor treatment, and improving the survival of cancer... | 1000 MILLIGRAM/SQ. METER, WEEKLY | DrugDosageText | CC BY | 34880877 | 20,296,465 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.
Pancreatic cancer has a poor prognosis, and it is traditionally treated with chemotherapy. Fortunately, immunotherapy has rapidly changed the landscape of solid tumor treatment, and improving the survival of cancer... | 125 MILLIGRAM/SQ. METER, WEEKLY | DrugDosageText | CC BY | 34880877 | 20,296,465 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Remediation of ABCG5-Linked Macrothrombocytopenia With Ezetimibe Therapy.
To investigate refractory hypercholesterolemia, a female patient and relatives were subjected to whole-genome sequencing. The proband was found to have compound heterozygous substitutions p. Arg446Gln and c.1118+3G>T in ABCG5, one of two genes ca... | ATORVASTATIN CALCIUM, EZETIMIBE | DrugsGivenReaction | CC BY | 34880906 | 20,467,869 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Remediation of ABCG5-Linked Macrothrombocytopenia With Ezetimibe Therapy.
To investigate refractory hypercholesterolemia, a female patient and relatives were subjected to whole-genome sequencing. The proband was found to have compound heterozygous substitutions p. Arg446Gln and c.1118+3G>T in ABCG5, one of two genes ca... | ATORVASTATIN | DrugsGivenReaction | CC BY | 34880906 | 20,497,668 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal distension'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic cirrhosis'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant ascites'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,816,334 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,816,334 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudocirrhosis'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Varices oesophageal'. | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | GIMERACIL\OTERACIL\TEGAFUR, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
What was the administration route of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
What was the outcome of reaction 'Abdominal distension'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Recovered | ReactionOutcome | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
What was the outcome of reaction 'Ascites'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Recovered | ReactionOutcome | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
What was the outcome of reaction 'Hepatic cirrhosis'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Recovered | ReactionOutcome | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
What was the outcome of reaction 'Malignant ascites'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Recovered | ReactionOutcome | CC BY-NC-ND | 34881031 | 20,816,334 | 2022-01 |
What was the outcome of reaction 'Pseudocirrhosis'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Recovered | ReactionOutcome | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
What was the outcome of reaction 'Varices oesophageal'? | Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer wa... | Recovered | ReactionOutcome | CC BY-NC-ND | 34881031 | 20,742,764 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Copper deficiency'. | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | CYANOCOBALAMIN, PREDNISONE, ZINC | DrugsGivenReaction | CC BY | 34881068 | 20,511,654 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | CYANOCOBALAMIN, PREDNISONE, ZINC | DrugsGivenReaction | CC BY | 34881068 | 20,511,654 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | CYANOCOBALAMIN, PREDNISONE, ZINC | DrugsGivenReaction | CC BY | 34881068 | 20,511,654 | 2021 |
What was the administration route of drug 'CYANOCOBALAMIN'? | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | Intramuscular | DrugAdministrationRoute | CC BY | 34881068 | 20,511,654 | 2021 |
What was the dosage of drug 'ZINC'? | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | TAKEN DAILY FOR MANY YEARS | DrugDosageText | CC BY | 34881068 | 20,511,654 | 2021 |
What was the outcome of reaction 'Copper deficiency'? | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | Recovering | ReactionOutcome | CC BY | 34881068 | 20,511,654 | 2021 |
What was the outcome of reaction 'Pancytopenia'? | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | Recovering | ReactionOutcome | CC BY | 34881068 | 20,511,654 | 2021 |
What was the outcome of reaction 'Paraesthesia'? | Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
Copper deficiency is a rare nutritional deficiency with hematological manifestations that mimic those found in myelodysplastic syndrome, a hematological malignancy incurable without allogeneic hematopoietic stem cell transplantation. Bone marrow ... | Not recovered | ReactionOutcome | CC BY | 34881068 | 20,511,654 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review.
Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depe... | MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34881070 | 20,206,212 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parvovirus B19 infection'. | Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review.
Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depe... | MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34881070 | 20,206,212 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polyomavirus viraemia'. | Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review.
Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depe... | MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34881070 | 20,206,212 | 2021 |
What was the outcome of reaction 'Anaemia'? | Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review.
Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depe... | Recovered | ReactionOutcome | CC BY | 34881070 | 20,206,212 | 2021 |
What was the outcome of reaction 'Parvovirus B19 infection'? | Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review.
Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depe... | Recovered | ReactionOutcome | CC BY | 34881070 | 20,206,212 | 2021 |
What was the outcome of reaction 'Polyomavirus viraemia'? | Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review.
Parvovirus B19 (PB19) is a single-stranded DNA virus that belongs to the Erythrovirus genus within the Parvoviridae family. Clinical presentations associated with PB19 infection vary greatly, depe... | Recovered | ReactionOutcome | CC BY | 34881070 | 20,206,212 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
BACKGROUND
Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still's disease (AOSD). The newly described... | ANAKINRA | DrugsGivenReaction | CC BY | 34884286 | 20,184,789 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
BACKGROUND
Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still's disease (AOSD). The newly described... | ANAKINRA | DrugsGivenReaction | CC BY | 34884286 | 20,184,789 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
BACKGROUND
Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still's disease (AOSD). The newly described... | ANAKINRA | DrugsGivenReaction | CC BY | 34884286 | 20,184,789 | 2021-11-27 |
What was the outcome of reaction 'Cardiac failure'? | USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
BACKGROUND
Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still's disease (AOSD). The newly described... | Fatal | ReactionOutcome | CC BY | 34884286 | 20,184,789 | 2021-11-27 |
What was the outcome of reaction 'Sepsis'? | USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients.
BACKGROUND
Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still's disease (AOSD). The newly described... | Fatal | ReactionOutcome | CC BY | 34884286 | 20,184,789 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac disorder'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, CYTARABINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, CYTARABINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, CYTARABINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, BORTEZOMIB, CYTARABINE, IBRUTINIB, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,252,357 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, BORTEZOMIB, CYTARABINE, IBRUTINIB, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,252,357 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,215,473 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Performance status decreased'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, BORTEZOMIB, CYTARABINE, IBRUTINIB, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,252,357 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostate cancer'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, CYTARABINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sarcoma'. | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BENDAMUSTINE, CYTARABINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
What was the dosage of drug 'BORTEZOMIB'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | BORTEZOMIB-BASED REGIMEN (N=4) | DrugDosageText | CC BY | 34885198 | 20,252,357 | 2021-12-03 |
What was the dosage of drug 'IBRUTINIB'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | 33 RECEIVED IBRUTINIB AS SECOND LINE THERAPY | DrugDosageText | CC BY | 34885198 | 20,252,357 | 2021-12-03 |
What was the dosage of drug 'LENALIDOMIDE'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | LENALIDOMIDE 2ND-LINE THERAPY(N=2) | DrugDosageText | CC BY | 34885198 | 20,252,357 | 2021-12-03 |
What was the outcome of reaction 'Cardiac disorder'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | Fatal | ReactionOutcome | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
What was the outcome of reaction 'Death'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | Fatal | ReactionOutcome | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
What was the outcome of reaction 'Disease progression'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | Fatal | ReactionOutcome | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
What was the outcome of reaction 'Prostate cancer'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | Fatal | ReactionOutcome | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
What was the outcome of reaction 'Sarcoma'? | Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
BACKGROUND
Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with m... | Fatal | ReactionOutcome | CC BY | 34885198 | 20,232,219 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | WARFARIN | DrugsGivenReaction | CC BY | 34886795 | 20,416,963 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | HEPARIN SODIUM, HUMAN PLASMA, REMDESIVIR, TADALAFIL, WARFARIN | DrugsGivenReaction | CC BY | 34886795 | 20,391,609 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epistaxis'. | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | HEPARIN SODIUM, HUMAN PLASMA, REMDESIVIR, TADALAFIL, WARFARIN | DrugsGivenReaction | CC BY | 34886795 | 20,391,609 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'International normalised ratio increased'. | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | WARFARIN | DrugsGivenReaction | CC BY | 34886795 | 20,416,963 | 2021-12-09 |
What was the dosage of drug 'HEPARIN SODIUM'? | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | DRIP | DrugDosageText | CC BY | 34886795 | 20,391,609 | 2021-12-09 |
What was the outcome of reaction 'Deep vein thrombosis'? | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | Recovering | ReactionOutcome | CC BY | 34886795 | 20,416,963 | 2021-12-09 |
What was the outcome of reaction 'Epistaxis'? | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | Recovered | ReactionOutcome | CC BY | 34886795 | 20,391,609 | 2021-12-09 |
What was the outcome of reaction 'International normalised ratio increased'? | Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report.
BACKGROUND
COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of havi... | Recovering | ReactionOutcome | CC BY | 34886795 | 20,416,963 | 2021-12-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Anti-programmed death (PD)-1 (aPD1) therapy is an effective treatment for metastatic melanoma (MM); however, over 50% of patients progress due to resistance. We tested a first-in-class immune-modula... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34887574 | 20,234,459 | 2021-12-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.